Search

21352
21354
21383
MIC Staff
Medicines Information Centre 021 406 6829
A Drug Information Service for Health Professionals provided by specially trained pharmacists. The Medicines Information Centre (MIC) is situated in the Division of Clinical Pharmacology, Department of Medicine at the University of Cape Town's...
MIC
HIV & TB Health Care Worker Hotline
HIV & TB Health Care Worker Hotline
The MIC, in collaboration with the Foundation for Professional Development (FPD) and PEPFAR/USAID, run the National HIV...
National Adverse Drug Reaction Hotline
National Adverse Drug Reaction Hotline
Do you require advice on the management of a suspected adverse drug reaction (ADR) in an HIV and/or TB patient? We provide information and advice to guide diagnosis and management of suspected adverse drug reactions.

News

Monday, 30 May 2016

In a March ‘Dear Doctor’ letter, Roche strengthened their advice on the use of mycophenolate mofetil (Cellcept®) in women of childbearing age and men. Mycophenolate is a known teratogen and is contraindicated during pregnancy.

Publication Date:
Wednesday, May 4, 2016 - 12:15

At the end of 2015, the MCC approved the use of the combination of tenofovir and emtricitibine (Truvada®) for pre-exposure prophylaxis of HIV (PrEP). Taking the combination tablet daily has been shown to be safe and effective in lowering the risk of HIV transmission.

Publication Date:
Wednesday, May 4, 2016 - 12:00